2,4-thiazolidinedione has been researched along with Colorectal Neoplasms in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
Excerpt | Relevance | Reference |
---|---|---|
" We have investigated the therapeutic properties of 5-[[6-[(2-fluorophenyl)-methoxy]-2-napthalenyl]-methyl]-2,4-thiazolidinedione (MCC-555) a PPARgamma agonist in human colorectal cancer cells." | 3.76 | MCC-555-induced NAG-1 expression is mediated in part by KLF4. ( Baek, SJ; Cekanova, M; Lee, SH; McEntee, MF, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cekanova, M | 1 |
Lee, SH | 1 |
McEntee, MF | 1 |
Baek, SJ | 1 |
1 other study available for 2,4-thiazolidinedione and Colorectal Neoplasms
Article | Year |
---|---|
MCC-555-induced NAG-1 expression is mediated in part by KLF4.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Gene Expression R | 2010 |